Clinical Guidelines

Clinical Guidelines for Nordic Walking

Last Updated: December 2025

These Clinical Guidelines are issued by the Nordic Walking Association of North America (NWANA) to support the safe, evidence-based implementation of Nordic Walking in clinical environments, rehabilitation settings, aging programs, chronic disease management, and medically supervised interventions.

1. Clinical Use Cases

  • Osteoarthritis (knee, hip, spine)
  • Cardiac rehabilitation (Phase II–III, physician-approved)
  • Metabolic disease management (obesity, prediabetes)
  • Neurological conditions (Parkinson’s, stroke recovery)
  • Cognitive decline, Alzheimer’s, MCI programs
  • Fall-prevention and balance training in older adults
  • Post-surgical mobility recovery (orthopedic/functional)
  • Postural and gait correction programs

2. Contraindication Screening

Before participating in Nordic Walking within a clinical program, patients must be screened for:

Absolute Contraindications

  • Unstable cardiac conditions without medical clearance
  • Acute joint inflammation requiring immobilization
  • Uncontrolled hypertension
  • Acute neurological episodes
  • High fall-risk without supervision

Relative Contraindications

  • Recent orthopedic surgery (requires surgeon clearance)
  • Severe balance impairment
  • Active pain > 6/10 during movement
  • Severe neuropathy or proprioceptive deficit

3. Clinical Clearance Pathway

Patient Intake → Clinical Screening → Doctor/Physio Approval → 
Baseline Mobility Test → Instructor Introduction → Controlled Sessions

4. Baseline Clinical Assessment

Performed before the first session:

  • Pain scale, ROM, gait pattern
  • Balance tests: tandem, semi-tandem, single-leg stance
  • Functional tests: 6MWT, STS-30, TUG (optional)
  • Heart rate, BP (if required by clinical team)

5. Clinical Session Structure

Warm-Up (5–8 minutes)

  • Slow walking + joint mobility
  • Posture alignment check
  • Breathing preparation

Technique Phase (10–15 minutes)

  • Arm swing mechanics
  • Pole placement and push application
  • Stride length adjustment
  • Postural reinforcement

Main Activity (15–35 minutes)

  • Low → moderate intensity progression
  • Gait symmetry monitoring
  • Heart rate or RPE-based adaptation

Cooldown (5–7 minutes)

  • Slow walking
  • Gentle stretching
  • Recovery breathing

6. Clinical Progression Model

Progression is individualized according to patient status.

Week 1–2: Technique-first, low intensity  
Week 3–4: Volume increase (time/distance)  
Week 5–6: Moderate intensity, controlled push phase  
Week 7–8: Independent session introduction (if permitted)

7. Red Flag Monitoring

Sessions must stop immediately if any of the following occur:

  • Sharp joint pain or swelling
  • Dizziness, confusion, visual disturbance
  • Chest pain or abnormal shortness of breath
  • Marked gait deterioration
  • Sudden loss of balance

8. Adaptations for Specific Conditions

Arthritis / Joint Degeneration

  • Reduced pole push; shorter stride
  • Soft-surface preference
  • Strict pain-monitoring protocol

Cardiac Conditions

  • RPE-based intensity control
  • No sudden speed changes
  • Extended warm-ups

Parkinson’s / Neurological Disorders

  • Cueing-based gait initiation
  • Dual-task only under supervision
  • Emphasis on rhythm and symmetry

Aging / Fall-Risk

  • Shorter sessions
  • Wider-base walking path
  • Close supervision

9. Clinical Pole Selection Standards

  • Correct height selection based on anthropometrics
  • Comfortable glove/strap fit
  • Cushioned tips for indoor or clinical flooring

10. Documentation Requirements

  • Session notes (duration, technique, patient response)
  • Incident reporting (if any)
  • Pain/effort logs (subjective)
  • Outcome measure tracking

11. Clinical Outcome Measures

  • 6-Minute Walk Test (6MWT)
  • Timed Up and Go (TUG)
  • Sit-to-Stand (STS-30)
  • Balance tests
  • Pain scales
  • Patient mobility questionnaires

12. Staff Requirements

  • Sessions led by NWANA-certified instructors
  • Clinical supervisors present if mandated by institution
  • All staff trained in stop-rules and adaptation protocols

13. Safety Escalation Pathway

Level 1 — Instructor  
Level 2 — Clinical Supervisor  
Level 3 — Lead Medical Provider  
Level 4 — Emergency Protocol (per institution policy)

Contact

For clinical partnerships, program design, or integration into rehabilitation or medical systems:

Email: info@nwaofna.com
Website: https://nwaofna.com